Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
April 08 2024 - 6:00AM
Business Wire
The fifth annual Report on Business editorial
benchmark identifies top-level Canadian businesses with the highest
executive gender diversity.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the
“Company” or “Organigram”), a leading licensed producer of
cannabis, is pleased to announce it has been recognized on the 2024
Report on Business ‘Women Lead Here’ list for gender diversity.
Fifty percent of the Company’s executive leadership team, including
its CEO, are women.
The Women Lead Here benchmark was established in 2020 and
applies a proprietary research methodology to provide an overview
of the largest Canadian corporations with the highest degree of
gender diversity among executive ranks. The ranked companies have
made tangible and organizational progress related to executive
gender parity.
“We are thrilled to be recognized yet again by the Globe &
Mail for the gender diversity within our leadership team.
Organigram is one of the very few companies in the cannabis
industry that has a significant female leadership presence within
its executive team and on its Board of Directors. Of note, our
Legal and Manufacturing departments are led by women, demonstrating
our commitment to breaking traditional gender stereotypes in
leadership roles,” said Beena Goldenberg, CEO of Organigram. “At
our company, we advocate for inclusivity, flexibility, and equality
in the corporate landscape. With women constituting over 46% of our
talented workforce, we prioritize inclusive recruitment strategies
and provide equitable opportunities for professional advancement
across the Company.”
For the 2024 ranking, Report on Business conducted a
journalistic analysis of approximately 500 large publicly traded
Canadian companies based on revenue, evaluating the ratio of
female-identifying to male-identifying executives in the top three
tiers of executive leadership. The resultant data was applied to a
weighted formula that also factored in company performance,
diversity and year-to-year change.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include
Organigram Inc. a licensed producer of cannabis, cannabis-derived
products and cannabis infused edibles in Canada. Organigram is
focused on producing high-quality, cannabis for patients and adult
recreational consumers, as well as developing international
business partnerships to extend the Company’s global footprint.
Organigram has also developed and acquired a portfolio of legal
adult-use recreational cannabis brands, including Edison, Holy
Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian,
Tremblant Cannabis and Trailblazer. Organigram operates facilities
in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a
dedicated edibles manufacturing facility in Winnipeg, Manitoba. The
Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240408838122/en/
For Media enquiries: Megan McCrae Senior Vice
President – Global Brands and Corporate Affairs
megan.mccrae@organigram.ca Organigram
For Investor Relations enquiries: Max Schwartz
Director of Investor Relations investors@organigram.ca
Organigram
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024